Topic · page 8 of 12

Across rheumatic diseases

Only studies that genuinely span several rheumatic diseases, such as drug safety and pharmacovigilance, infection, vaccination and comorbidity (cardiovascular, cancer, mental health) across diseases, and health services and quality of care across diseases. Never a fallback for an article that is hard to place

Briefs 281–320 of 474 placed here, newest publication first

Briefs in Across rheumatic diseases

Newest publication first

Arthritis Care Res (Hoboken)10 Mar 2024
Classifying Multimorbidity Using Drug Concepts via the Rx‐Risk Comorbidity Index: Methods and Comparative Cross‐Sectional Study
Cross-sectional study
RMD Open6 Mar 2024
Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System
Cohort study
Ann Intern Med5 Mar 2024
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study
Cohort study
J Rheumatol1 Mar 2024
Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease
Cohort study
Semin Arthritis Rheum29 Feb 2024
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets
Guideline or statement
Arthritis Care Res (Hoboken)29 Feb 2024
“What Came First?” Population‐Based Evaluation of Health Care Encounters for Depression and Anxiety Before and After Inflammatory Arthritis Diagnosis: Disentangling the Relationship Between Mental Health and Arthritis
Cohort study
Lancet Rheumatol22 Feb 2024
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
Secondary analysis
Arthritis Rheumatol20 Feb 2024
Vitamin D and Marine n‐3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double‐Blind, Placebo‐Controlled Trial
Randomized controlled trial
Semin Arthritis Rheum15 Feb 2024
Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study
Cohort study
Ann Rheum Dis15 Feb 2024
Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO)
Cross-sectional study
Semin Arthritis Rheum13 Feb 2024
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group
Guideline or statement
Clin Exp Rheumatol9 Feb 2024
Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virus
Cohort study
Semin Arthritis Rheum5 Feb 2024
Standardization of interstitial lung disease assessment by ultrasound: results from a Delphi process and web-reliability exercise by the OMERACT ultrasound working group
Guideline or statement
J Rheumatol1 Feb 2024
Short- and Long-Term Mortality of Hospitalized Patients With Autoimmune Rheumatic Diseases and Serious Infections: A National Cohort Study
Cohort study
Lupus Sci Med31 Jan 2024
Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases
Diagnostic or prognostic study
RMD Open30 Jan 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease
Cohort study
Semin Arthritis Rheum26 Jan 2024
Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases
Cohort study
Clin Exp Rheumatol25 Jan 2024
Description of self-efficacy for managing symptoms and emotions in a large rheumatology clinic population
Cross-sectional study
RMD Open22 Jan 2024
Prevalence of anxiety and depression and the association with self-management behaviour in >12 000 patients with inflammatory rheumatic disease: a cross-sectional nationwide study
Cross-sectional study
RMD Open18 Jan 2024
Effect of high-intensity interval training in physiotherapy primary care for patients with inflammatory arthritis: the ExeHeart randomised controlled trial
Randomized controlled trial
Arthritis Care Res (Hoboken)18 Jan 2024
Using Electronic Health Records and Linked Claims Data to Assess New Medication Use and Primary Nonadherence in Rheumatology Patients
Cohort study
Clin Exp Rheumatol17 Jan 2024
Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism
Cohort study
Arthritis Rheumatol17 Jan 2024
Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register
Diagnostic or prognostic study
J Rheumatol15 Jan 2024
Association of Serum Soluble Transferrin Receptor Concentration With Markers of Inflammation: Analysis of 1001 Patients From a Tertiary Rheumatology Center
Cross-sectional study
Semin Arthritis Rheum11 Jan 2024
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada
Cohort study
Ann Rheum Dis11 Jan 2024
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping
Cross-sectional study
RMD Open10 Jan 2024
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review
Meta-analysis
Rheumatology (Oxford)5 Jan 2024
Risk of non-thyroidal autoimmune diseases in patients with Graves’ disease: a nationwide retrospective cohort study
Cohort study
Rheumatology (Oxford)4 Jan 2024
Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases
Cohort study
Clin Exp Rheumatol27 Dec 2023
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
Case-control study
Clin Exp Rheumatol18 Dec 2023
Performance of a novel high-resolution infrared thermography marker in detecting and assessing joint inflammation: a comparison with joint ultrasound
Diagnostic or prognostic study
Semin Arthritis Rheum16 Dec 2023
Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases
Guideline or statement
RMD Open14 Dec 2023
Daratumumab for autoimmune diseases: a systematic review
Meta-analysis
Lancet Rheumatol12 Dec 2023
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Randomized controlled trial
Clin Exp Rheumatol12 Dec 2023
Association between Mycobacterium tuberculosis infection and the risk of inflammatory arthritides
Cohort study
Arthritis Care Res (Hoboken)12 Dec 2023
COVID‐19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice Network
Cross-sectional study
Rheumatology (Oxford)9 Dec 2023
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study
Cohort study
RMD Open6 Dec 2023
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
Meta-analysis
RMD Open6 Dec 2023
Hepatitis B vaccination associated with low response in patients with rheumatic diseases treated with biologics
Cohort study
RMD Open1 Dec 2023
Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated
Cohort study

All 474 Briefs in ExploreShowing Briefs 281–320 of 474, newest first